Register
Login:
Share:
Email Facebook Twitter




Immupharma Share Chat (IMM)



Share Price: 29.00Bid: 29.00Ask: 30.00Change: 1.00 (+3.57%)Riser - Immupharma
Spread: 1.00Spread as %: 3.45%Open: 29.00High: 29.00Low: 29.00Yesterday’s Close: 28.00


Share Discussion for Immupharma


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


hunkymonkey
Posts: 1,807
Off Topic
Opinion:No Opinion
Price:29.00
More centres more patients
Today 17:00
We are moving forward (very slowly) but as each step is taken we are a step closer. It's clear that nothing disastrous is happening within the trials, otherwise they wouldn't be opening more. Kefi starting to gather momentum, which means top slice and top up here.
Lupazor patented for another 10 years, reading around pharmaceuticals, I feel extremely confident of a buy out here if approved.
I will not band around the figures, but lupazor appears to have taken a step forward in medicine, being able to treat auto-immune diseases in a totally different way. The adaption to treat other diseases offers more scope and development. If the results are repeated it will be great for the sufferers of this and other diseases. For these reasons as well as 10 years of treating with little competition, I feel very optimistic of a buyout.
 
Mcowboy
Posts: 85
Off Topic
Opinion:No Opinion
Price:28.00
Lupuzor phase 3 trials
Today 13:19
Within Europe, as well as France the trials are now on ongoing in Hungary: https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003341-25/HU
Mcowboy
Posts: 85
Off Topic
Opinion:No Opinion
Price:27.00
News
Mon 08:29
Hopefully we might get some further news on Thursday to coincide with the AGM. Anyone attending?
hunkymonkey
Posts: 1,807
Off Topic
Opinion:No Opinion
Price:28.00
RE: nothing needed
Thu 12:46
Those two trades look like someone has a bit of ocd about round numbers. It's been about 8weeks since European sites opened, approximately that's how long it took to start dosing in America. Surely we should be close.
We need 200 patients to complete the study. Does anyone/could we find out how many have actually been dosed in America up to press?
jollyspeculator
Posts: 20,425
Off Topic
Opinion:Buy
Price:26.50
nothing needed
Thu 09:40
moving up
hunkymonkey
Posts: 1,807
Off Topic
Opinion:No Opinion
Price:26.50
RE: News
17 May '16
Yeah need something, but funds diverted away from lupazor trials probably mean more rising before the end of the trials.
seagul
Posts: 163
Off Topic
Opinion:No Opinion
Price:27.25
News
17 May '16
Could do with something to get this moving
sicilian_kan
Posts: 342
Observation
Opinion:No Opinion
Price:26.50
News Due
12 May '16
From the results last week - sounds like we will be getting some more data and an RNS: (***emphasis*** added)

Announced Today: Prof. Sylviane Muller: London Lupuzor Symposium June 8 & 9, 2016

-- A number of key symposiums will be hosted during this two day event where Prof. Muller will present on the unique 'Mechanism of Action' of Lupuzor(TM), also known by its chemical name 'Forigerimod' or 'P140'. ***Prof. Muller will also provide further evidence of the role the P140 molecule can take in the potential treatment of other autoimmune diseases.***
hunkymonkey
Posts: 1,807
Off Topic
Opinion:No Opinion
Price:26.50
RE: Imm
12 May '16
Absolutely - it the nature of the beast. It's going to be in the dark until final results are approved. The all the precious results are there, but as far as a drug goes - this is as de-risked as it can be.

There will be lots of buying opportunity over the next year, but I can't see this dropping out of the 20s, more likely creep into and hold 30s.

Actually when you think about it, every month that passes with no news, is actually good news for lupazor. I do think that should they start spending on the other drugs, they will need to raise funds before the end of the trials. £8mln doesn't go a long way really in pharmaceuticals
hamila01
Posts: 442
Off Topic
Opinion:No Opinion
Price:26.50
View Thread (2)
Imm
12 May '16
It's going to be a slow couple of years whilst the trial trundles along.

My big hope is that we'll get news regarding other possible applications of the technology behind Lupozor and other compounds in development to fill the void before trial results.

GLA LTH's




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.